AKT1 and hepatocellular carcinoma: Second, we only analyzed ZNF191/DNMT1/p‐AKT axis in hepatoma cells (Figure 6E), thus our proposed signal pathway regulation requires further validation in mouse models of liver cancer and HCC patients.